On the Frontlines of Psoriasis
Stay up to date on the latest advancements in the management of one of the most common types of skin diseases with our exclusive podcast series, On the Frontlines of Psoriasis. Tune in to hear from leading dermatology experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s reshaping our understanding of this common and chronic disease.
16-30 of 40
Nail Psoriasis: Evaluating Quality-of-Life Measures and Treatment Gaps
On the Frontlines of PsoriasisNail Psoriasis: Evaluating Quality-of-Life Measures and Treatment Gaps
Charles Turck, PharmD, BCPS, BCCCP
Shari Lipner, MD
Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
On the Frontlines of PsoriasisGenetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
Audrey Bui, DO
Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
On the Frontlines of PsoriasisSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Joel M. Gelfand, MD, MSCE, FAAD
Michael S. Garshick, MD
Comparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study
On the Frontlines of PsoriasisComparing Home and Office-Based UVB Phototherapy: Insights from the LITE Study
Charles Turck, PharmD, BCPS, BCCCP
Joel M. Gelfand, MD, MSCE, FAAD
Valerie Harrison, PhD
Examining Psoriasis Prevalence: Diagnostic Differences Across Demographics
On the Frontlines of PsoriasisExamining Psoriasis Prevalence: Diagnostic Differences Across Demographics
Joe K. Tung, MD, MBA
Looking Beyond the Skin: The Far-Reaching Impacts of Psoriasis
On the Frontlines of PsoriasisLooking Beyond the Skin: The Far-Reaching Impacts of Psoriasis
Philip J. Mease, MD
- advertisement
Scalp Psoriasis Care: When Should Systemic Therapy Be Considered?
On the Frontlines of PsoriasisScalp Psoriasis Care: When Should Systemic Therapy Be Considered?
Andrew Blauvelt, MD, MBA
Future Directions in Psoriasis Treatment: Innovations and Implications
On the Frontlines of PsoriasisFuture Directions in Psoriasis Treatment: Innovations and Implications
Andrew Blauvelt, MD, MBA
Examining the Mediterranean Diet’s Potential in Psoriasis Management
On the Frontlines of PsoriasisExamining the Mediterranean Diet’s Potential in Psoriasis Management
Charles Turck, PharmD, BCPS, BCCCP
Joel M. Gelfand, MD, MSCE
Psoriasis and Mortality: New Data on Life Expectancy
On the Frontlines of PsoriasisPsoriasis and Mortality: New Data on Life Expectancy
Robert Gniadecki, MD
Scalp Psoriasis Treatment: Examining Deucravacitinib’s Efficacy and Safety
On the Frontlines of PsoriasisScalp Psoriasis Treatment: Examining Deucravacitinib’s Efficacy and Safety
Andrew Blauvelt, MD, MBA
Long-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings
On the Frontlines of PsoriasisLong-Term Safety of Ixekizumab for Psoriasis: A Review of Key Findings
Atul A. Deodhar, MD, MRCP
- advertisement
Factors Influencing Biologic Therapy Switching in Psoriasis and Psoriatic Arthritis
On the Frontlines of PsoriasisFactors Influencing Biologic Therapy Switching in Psoriasis and Psoriatic Arthritis
Philip J. Mease, MD
UV-B Phototherapy for Psoriasis: Comparing Home-Based and Office-Based Treatment
On the Frontlines of PsoriasisUV-B Phototherapy for Psoriasis: Comparing Home-Based and Office-Based Treatment
Joel M. Gelfand, MD, MSCE
Pediatric Psoriasis: Clinical Presentation and Topical Treatment Strategies
On the Frontlines of PsoriasisPediatric Psoriasis: Clinical Presentation and Topical Treatment Strategies
Lawrence F. Eichenfield, MD
